Search results
2 cze 2020 · Of those responders who treated their dogs with isoxazolines (1,325) 80.1% reported adverse effects in their pets. Serious AE were noted in 4.55 to 14.79% of animals given isoxazolines (Tables 5 and 6 ).
19 cze 2013 · This systematic review provides evidence-based evaluation of the data on the adverse effects affecting dogs after the use of the most contemporary NSAIDs. Few studies were designed in a randomized, controlled, and blinded manner using a clinical population of dogs.
25 lis 2013 · The Study Group recommends empirical application of immunosuppressive therapy for dogs with severe, persistent, or progressive glomerular disease in which there is evidence of an active immune-mediated pathogenesis on kidney biopsy and no identified contraindication to immunosuppressive therapy.
17 wrz 2018 · This article summarizes the following biomarkers that have been evaluated in dogs with CIE during the last decade, and critically evaluates their potential clinical utility in dogs with CIE: functional biomarkers (cobalamin, methylmalonic acid, folate, α 1 ‐proteinase inhibitor, immunoglobulin A), biochemical biomarkers (C‐reactive protein, peri...
1 mar 2011 · Side effects of gold salts include blood dyscrasias, diarrhea, ulceration of mucous membranes, erythema multiforme, hepatotoxicosis, and renal disease35 and may limit their use in some patients. Thus, close monitoring during therapy is critical.
This article overviews the drugs used in the treatment of IBD depend-ing on the intensity of clinical symptoms (Canine Inflammatory Bowel Disease Activity Index and Canine Chronic Enterophaty Clinical Activity Index).
8 sie 2023 · The FDA is alerting pet owners and veterinarians of the potential for neurologic adverse events in dogs and cats when treated with drugs that are in the isoxazoline class.
